BioXcel Therapeutics BTAI Q1 2026 Earnings EPS Misses Expectations as PreRevenue Biotech Focuses on Pipeline Progress CCEP Q4 2018 Earnings Modest EPS Miss Amidst Quiet Quarter HRI Q1 2026 Earnings Strong EPS Beat Surprises Market QRHC Q1 2026 Earnings EPS Misses Estimates as Stock Rises Slightly FSP Q4 2025 Earnings Profitability Surprise as EPS Turns Positive DLTH Q1 2026 Earnings EPS Surges Past Estimates Driving Shares Higher